Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000098

Chief Medical Officer sold 7,947 shares at an average $92.38 ($734,145)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-15 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 36,218 D
2026-09-15 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 39,718 D
2026-09-15 Sale : show line 3 in the form 10b5-1 −2,384 $91.10 $217,173 37,334 D
2026-09-15 Sale : show line 4 in the form 10b5-1 −3,150 $92.03 $289,890 34,184 D
2026-09-15 Sale : show line 5 in the form 10b5-1 −1,366 $92.99 $127,023 32,818 D
2026-09-15 Sale : show line 6 in the form 10b5-1 −100 $94.22 $9,422 32,718 D
2026-09-15 Sale : show line 7 in the form 10b5-1 −947 $95.71 $90,637 31,771 D
Open-market sales · 7,947 sh · avg $92.38 · $734,145

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-15 Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 193,563 D
2026-09-15 Exercise or conversion : show line 9 in the form 10b5-1 Employee Warrant (right to buy) −3,500 164,992 D
Loading xslF345X06/form4.xml…